Pamukcuoglu, M., Baysal, N. A., & Pepeler, M. S. (2021). The infection rate in new diagnosis and relapsed/refractory multiple myeloma patients who had bortezomib-based chemotherapy and relationship between development of infection and lymphocyte/monocyte ratio. The European Research Journal, 7(6), 541-549. https://doi.org/10.18621/eurj.855510